Triphenylen-2-ylboronic acid | CAS:654664-63-8

We serve Triphenylen-2-ylboronic acid CAS:654664-63-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Triphenylen-2-ylboronic acid

Chemical Name:Triphenylen-2-ylboronic acid
CAS.NO:654664-63-8
Synonyms:Boronic acid, B-2-triphenylenyl-
2-Triphenylenylboronic acid
Molecular Formula:C18H13BO2
Molecular Weight:272.10600
 
Physical and Chemical Properties:
Index of Refraction:1.762
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like Triphenylen-2-ylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Triphenylenylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boronic acid, B-2-triphenylenyl- Use and application,Boronic acid, B-2-triphenylenyl- technical grade,usp/ep/jp grade.


Related News: ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.2-(3,4-dimethylphenyl)-5-methyl-4H-pyrazol-3-one manufacturer The new rules started Saturday — however if you’re an Australian citizen, permanent resident or their immediate family, or an aircrew member who has been using appropriate protective equipment, you’re exempt.8-Chloro-1-octanol supplier The new rules started Saturday — however if you’re an Australian citizen, permanent resident or their immediate family, or an aircrew member who has been using appropriate protective equipment, you’re exempt.trimethoxy(2-methylpropyl)silane vendor “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.“Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.